Uninsured women with breast cancer were nearly 2.6 times more likely to have a late stage diagnosis than cancer patients who were insured, finds a new study from Kimberly Johnson, associate professor at the Brown School.
The National Institutes of Health has awarded a Washington University in St. Louis faculty member in the School of Engineering & Applied Science a total of $1.3 million to study new imaging techniques designed to better fight breast and ovarian cancers.
Researchers at The McDonnell Genome Institute at the School of Medicine have co-led a study on breast tumors — before and after hormone reduction therapy. It reveals the extreme genetic complexity of these tumors and the variety of responses that are possible to estrogen-deprivation treatments.
Delaying radiation therapy too long after surgery significantly increases the risk of recurrent tumors in women treated for very early, or what is referred to as “stage 0,” breast cancer, according to new research at the School of Medicine.
Breast cancer takes a daunting toll on all women, but it hits younger women especially hard, finds a new study from the Brown School. Women aged 18-44 with a history of breast cancer reported a lower health-related quality of life than older survivors, highlighting the impact of breast cancer on the physical and mental health of younger women.
In a new analysis, researchers at the School of Medicine have shed light on the hereditary elements across 12 cancer types — showing a surprising inherited component to stomach cancer and providing some needed clarity on the consequences of certain types of mutations in well-known breast cancer susceptibility genes BRCA1 and BRCA2.
High-dose vitamin D relieves joint and muscle pain for many breast cancer patients taking estrogen-lowering drugs, according to a new study from Washington University School of Medicine in St. Louis.
A free e-book by researchers at Washington University School of Medicine provides practical, science-based advice for lowering breast cancer risk at every stage of life. “Together — Every Woman’s Guide to Preventing Breast Cancer” is written for a lay audience to help women improve their breast health and the breast health of their loved ones.
William Gillanders, MD, a physician-scientist and avid cyclist, keeps the wheels turning in the race against breast cancer. His career goal is to change treatment paradigms by making breast cancer vaccines a reality for those being treated for the disease.
A breast cancer vaccine developed at the School of Medicine is safe in patients with metastatic breast cancer, results of an early clinical trial indicate. Preliminary evidence from the small clinical trial, led by William Gillanders, MD, also suggests that the vaccine primed the patients’ immune systems to attack tumor cells and helped slow the cancer’s progression.